Clinical trials in Craiova – page 21

322 clinical trials in Craiova, Romania across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in RomaniaStudii.Clinice.ro

Craiova at a glance

322

clinical trials

Research sites3

Quick filters

322 trials in Craiova

Open in trial search

Non-small cell lung cancer stage IV

Not recruiting

Study Comparing Nivolumab and Ipilimumab with Chemotherapy to Chemotherapy Alone for Patients with Stage IV Non-Small Cell Lung Cancer

Registered drugNo placebo

Study Comparing Nivolumab and Ipilimumab with Chemotherapy to Chemotherapy Alone for Patients with Stage IV Non-Small Cell Lung Cancer

Registered drugNo placebo

Romania

Participants:18–64 years · 65+ years
Substances:Carboplatin
Sponsor:Bristol Myers Squibb International Corporation

Contact Research Centre

Prostate cancer metastatic

Not recruiting

Study of Apalutamide and Androgen Deprivation Therapy for Patients with Metastatic Hormone-sensitive Prostate Cancer

Registered drug

Study of Apalutamide and Androgen Deprivation Therapy for Patients with Metastatic Hormone-sensitive Prostate Cancer

Registered drug

Romania

Participants:18–64 years · 65+ years
Substances:Apalutamide
Sponsor:Janssen Cilag International

Contact Research Centre

Myelofibrosis+1

Not recruiting

Study on Luspatercept for Treating Anemia in Adults with Myelofibrosis on JAK2 Inhibitor Therapy Requiring Red Blood Cell Transfusions

Registered drug

Study on Luspatercept for Treating Anemia in Adults with Myelofibrosis on JAK2 Inhibitor Therapy Requiring Red Blood Cell Transfusions

Registered drug

Romania

Participants:18–64 years · 65+ years
Substances:Luspatercept
Sponsor:Celgene Corp.

Contact Research Centre

Malignant melanoma

Not recruiting

Study of Fianlimab and Cemiplimab for Patients with Untreated Advanced Melanoma

Registered drug

Study of Fianlimab and Cemiplimab for Patients with Untreated Advanced Melanoma

Registered drug

Romania

Participants:0–17 years · 18–64 years · 65+ years
Substances:Cemiplimab
Sponsor:Regeneron Pharmaceuticals Inc.

Contact Research Centre

Schizophrenia

Not recruiting

Study on Valbenazine for Patients with Schizophrenia Not Responding Well to Antipsychotic Treatment

Investigational

Study on Valbenazine for Patients with Schizophrenia Not Responding Well to Antipsychotic Treatment

Investigational

Romania

Participants:18–64 years · 65+ years
Substances:Valbenazine Ditosylate
Sponsor:Neurocrine Biosciences Inc.

Contact Research Centre

Transitional cell carcinoma

Not recruiting

Study on Nivolumab and Ipilimumab for Patients with Untreated Unresectable or Metastatic Urothelial Cancer

Registered drugNo placebo

Study on Nivolumab and Ipilimumab for Patients with Untreated Unresectable or Metastatic Urothelial Cancer

Registered drugNo placebo

Romania

Participants:18–64 years · 65+ years
Substances:Carboplatin
Sponsor:Bristol-Myers Squibb Services Unlimited Company

Contact Research Centre

HER2 positive breast cancer

Not recruiting

Study on Atezolizumab and Trastuzumab Emtansine for Patients with HER2-Positive Breast Cancer at High Risk of Recurrence After Preoperative Therapy

Registered drug

Study on Atezolizumab and Trastuzumab Emtansine for Patients with HER2-Positive Breast Cancer at High Risk of Recurrence After Preoperative Therapy

Registered drug

Romania

Participants:18–64 years · 65+ years
Substances:Atezolizumab
Sponsor:F. Hoffmann-La Roche AG

Contact Research Centre

Asthma

Not recruiting

Study on the Effectiveness and Safety of Fluticasone Propionate and Salbutamol Sulfate for Patients with Asthma

InvestigationalNo placebo

Study on the Effectiveness and Safety of Fluticasone Propionate and Salbutamol Sulfate for Patients with Asthma

InvestigationalNo placebo

Romania

Participants:0–17 years · 18–64 years · 65+ years
Substances:Salbutamol Sulfate
Sponsor:Teva Branded Pharmaceutical Products R&D LLC

Contact Research Centre

Renal cell carcinoma

Not recruiting

Study of Belzutifan with Lenvatinib versus Cabozantinib in Adults with Advanced Renal Cell Carcinoma Who Have Previously Received Anti-PD-1/L1 Treatment

Registered drugNo placebo

Study of Belzutifan with Lenvatinib versus Cabozantinib in Adults with Advanced Renal Cell Carcinoma Who Have Previously Received Anti-PD-1/L1 Treatment

Registered drugNo placebo

Romania

Participants:18–64 years · 65+ years
Substances:Belzutifan
Sponsor:Merck Sharp & Dohme LLC

Contact Research Centre

Squamous cell carcinoma of lung

Not recruiting

Study of Pembrolizumab, Carboplatin, and Paclitaxel for Patients with Metastatic Squamous Non-small Cell Lung Cancer

Registered drug

Study of Pembrolizumab, Carboplatin, and Paclitaxel for Patients with Metastatic Squamous Non-small Cell Lung Cancer

Registered drug

Romania

Participants:18–64 years · 65+ years
Substances:Carboplatin
Sponsor:Merck Sharp & Dohme LLC

Contact Research Centre

Squamous cell carcinoma of lung+3

Not recruiting

Study Comparing Subcutaneous and Intravenous Pembrolizumab with Chemotherapy for Patients with Metastatic Non-Small Cell Lung Cancer

Registered drugNo placebo

Study Comparing Subcutaneous and Intravenous Pembrolizumab with Chemotherapy for Patients with Metastatic Non-Small Cell Lung Cancer

Registered drugNo placebo

Romania

Participants:18–64 years · 65+ years
Substances:Carboplatin
Sponsor:Merck Sharp & Dohme LLC

Contact Research Centre

Hormone receptor positive breast cancer

Not recruiting

Study of OP-1250 for Treating Advanced or Metastatic ER+, HER2- Breast Cancer in Patients After Endocrine and CDK4/6 Inhibitor Therapy

Registered drugNo placebo

Study of OP-1250 for Treating Advanced or Metastatic ER+, HER2- Breast Cancer in Patients After Endocrine and CDK4/6 Inhibitor Therapy

Registered drugNo placebo

Romania

Participants:18–64 years · 65+ years
Substances:Anastrozole
Sponsor:Olema Pharmaceuticals Inc.

Contact Research Centre

Other cities in Romania

The busiest research cities in the country

All 65 cities in Romania

Clinical research in Craiova

What the registry says about research in the country

01 Respiratory Medicine

Current trials focus on innovative treatments for pulmonary conditions, including investigations into new therapies for asthma and pulmonary fibrosis. Research evaluates medication effectiveness in improving lung function and breathing capacity.

Idiopathic Pulmonary Fibrosis
Uncontrolled Asthma
Non-small Cell Lung Cancer

Studies incorporate both targeted therapies and combination treatments to address various stages of respiratory diseases.

02 Oncology

Groundbreaking research in cancer treatment explores novel therapeutic approaches for various types of cancer, with particular focus on gastric, prostate, and lung cancers.

Metastatic Gastric Cancer
Prostate Cancer
Head and Neck Cancer
Breast Cancer

Trials evaluate combination therapies and immunotherapy approaches for improved patient outcomes.

03 Cardiovascular and Metabolic

Studies focus on preventing and treating heart failure and related conditions, with innovative approaches to cardiovascular disease management and metabolic disorders.

Heart Failure Prevention
Chronic Kidney Disease
Cardiovascular Disease
Weight Management

Research emphasizes both preventive strategies and treatment interventions for cardiovascular conditions.

04 Immunology

Advanced research in autoimmune conditions and inflammatory disorders, investigating new therapeutic options for various immune-mediated diseases.

Plaque Psoriasis
Psoriatic Arthritis
Chronic Immune Thrombocytopenia
Chronic Rhinosinusitis

Studies evaluate both targeted therapies and broader immunological approaches.

05 Neurology and Mental Health

Innovative research addressing neurological disorders and mental health conditions, with focus on both therapeutic interventions and disease management.

Alzheimer's Disease Psychosis
Major Depressive Disorder

Trials explore novel treatment approaches for complex neurological and psychiatric conditions.

Back to Romania All countries